---
figid: PMC11953998__gr17
figtitle: Nanomedicine strategies for precise tumor therapy through escaping proteasomal
  degradation pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11953998
filename: gr17.jpg
figlink: /pmc/articles/PMC11953998/figure/F17/
number: F17
caption: Nanomedicine strategies for precise tumor therapy through escaping proteasomal
  degradation pathways. (a) Schematic illustration of proteasome escape pathway in
  precise tumor therapy. (Created with BioRender.com.) (b) Proteasome inhibitor-encapsulated
  CuS/carbon dots nanocomposites enhanced PTT treatment by stabilizing substrates
  in the proteasomal degradation pathway [305]. (Reproduced with permission, copyright
  2020, ACS Publication.) (c) BCMA-BTZ-NPs inhibited proteasomal degradation, causing
  toxic protein accumulation, apoptosis, enhanced ICD, and tumor-specific cytotoxicity
  in resistant cells [311]. (Reproduced with permission, copyright 2023, Nature Portfolio.)
papertitle: 'Organelle-oriented nanomedicines in tumor therapy: Targeting, escaping,
  or collaborating?'
reftext: Kexin Tan, et al. Bioact Mater. 2025 Jul;49(NA).
year: '2025'
doi: 10.1016/j.bioactmat.2025.02.040
journal_title: Bioactive Materials
journal_nlm_ta: Bioact Mater
publisher_name: KeAi Publishing
keywords: Organelle targeting | Nanomedicine | Precise tumor therapy | Escape | Collaboration
automl_pathway: 0.9161982
figid_alias: PMC11953998__F17
figtype: Figure
redirect_from: /figures/PMC11953998__F17
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11953998__gr17.html
  '@type': Dataset
  description: Nanomedicine strategies for precise tumor therapy through escaping
    proteasomal degradation pathways. (a) Schematic illustration of proteasome escape
    pathway in precise tumor therapy. (Created with BioRender.com.) (b) Proteasome
    inhibitor-encapsulated CuS/carbon dots nanocomposites enhanced PTT treatment by
    stabilizing substrates in the proteasomal degradation pathway [305]. (Reproduced
    with permission, copyright 2020, ACS Publication.) (c) BCMA-BTZ-NPs inhibited
    proteasomal degradation, causing toxic protein accumulation, apoptosis, enhanced
    ICD, and tumor-specific cytotoxicity in resistant cells [311]. (Reproduced with
    permission, copyright 2023, Nature Portfolio.)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASC3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TP53
  - TP63
  - TP73
  - HMBS
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - NM
  - NOC2L
  - Bortezomib
  - Nucleus
---
